Germany’s switch committee, the SVA, remains unconvinced with regards to the OTC availability of erectile dysfunction drugs sildenafil and tadalafil, as evidenced by the recently published full minutes of its last meeting on 11 July.
Why Did Germany’s Switch Experts Reject OTC Tadalafil And Sildenafil (Again)?
Germany's Expert Committee for Prescription has once again rejected the OTC switch of sildenafil, as well as tadalafil. The recently published full meeting minutes show key concerns were falsification, misuse and OTC pricing.